Purchase Order 75N91024P00527
- Not listed
- This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Akoya Biosciences, Inc. (doing business as Phenoptics), a for-profit small disadvantaged business. The $16,560 contract is for a maintenance agreement on an Akoya Mantra quantitative imaging system (serial number MN1548N0024) located at the NCI campus in Bethesda, Maryland. The award does not utilize a set-aside and has an ultimate...
- This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Cancer Institute to Akoya Biosciences, Inc., a self-certified small disadvantaged business. The contract has a potential value of $16,560.00 and a period of performance through April 30, 2025. Akoya, operating under the trade name Phenoptics, will provide goods and services to support medical imaging, diagnostic testing, and pathology operations. This includes the delivery of OPAL reagent packs,...
- Akoya Biosciences, Inc., doing business as Phenoptics, has been awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract has a potential value of $11,417 and calls for Akoya to provide services in support of the agency's medical imaging, diagnostic testing, and pathology operations located in Bethesda, Maryland. No set-aside designation was applied to this award. Akoya specializes in spatial...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute to Akoya Biosciences, Inc. (doing business as Phenoptics), a self-certified small disadvantaged business manufacturer of goods, for a service contract to provide a PhenoCycler instrument. The total ceiling value of the contract is $10,020.00, and the ultimate completion date is July 30, 2025. The award is not associated with a set-aside program. Akoya Biosciences is a biotechnology company that specializes in...
- This federal contract award is for the procurement of PHENOCYCLER REAGENTS by the National Cancer Institute (NCI), a civilian agency under the U.S. Department of Health and Human Services. The $12,737.00 firm fixed price purchase order was awarded to Akoya Biosciences, Inc., doing business as Phenoptics, a for-profit biotechnology company and manufacturer of goods. This contract is not designated as a small business set-aside. Akoya Biosciences has been awarded numerous federal contracts and...
- This is a $12,000 firm fixed price purchase order awarded by the National Cancer Institute to Akoya Biosciences, Inc. (doing business as Phenoptics), a self-certified small disadvantaged business. The contract is for software upgrades, with a period of performance through July 17, 2024. Akoya Biosciences specializes in spatial phenotyping and provides medical imaging, diagnostic testing, and pathology products and services to support healthcare operations, including for the Department of...
- The National Cancer Institute awarded a purchase order to Akoya Biosciences, Inc. for $15,300.00 on April 15, 2020, with ultimate completion by April 30, 2021. The order is firm fixed-price with no set-aside used. Work is performed in Bethesda, Maryland. Akoya, a small disadvantaged business and biotechnology company specializing in spatial phenotyping and tissue imaging solutions, supplies specialized imaging systems, reagents, and diagnostic technologies to support federal healthcare and...
- This federal contract award was made by the National Institute of Dental and Craniofacial Research (NIDCR), a civilian agency under the National Institutes of Health (NIH), to Akoya Biosciences, Inc., doing business as Phenoptics. The $98,600 firm-fixed-price purchase order is for the delivery of Codex fluidics instrumentation, which are specialized laboratory equipment for medical research applications. The contract has no set-aside designation and was awarded on a competitive, non-set-aside...
- This federal contract award is for annual preventative maintenance and services for a slide microscope scanner. The contract was awarded to Akoya Biosciences, Inc., doing business as Phenoptics, a biotechnology company that specializes in spatial phenotyping and advanced tissue imaging solutions. The contract has a ceiling value of $111,816.00 and a period of performance through May 7, 2026. The contracting agency is the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1...
- <p>The National Cancer Institute awarded a purchase order to Akoya Biosciences, Inc. for $14,844.00 on March 27, 2019, with an ultimate completion date of April 30, 2020. Performance occurs in Menlo Park, California. The order is for a service agreement priced on a firm fixed-price basis. Akoya is a small disadvantaged business and manufacturer of advanced tissue imaging and spatial phenotyping solutions.</p>
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Akoya Biosciences, Inc. (doing business as Phenoptics), a for-profit manufacturer of medical imaging equipment and reagents. The contract, valued at $195,720, is for preventive maintenance services on one Akoya PhenoImager HT instrument over a 5-year period from July 2024 to June 2029. This award is not a set-aside contract. Akoya Biosciences has secured numerous federal contracts with the NCI and Department of Veterans Affairs to provide specialized imaging systems, reagents, and associated services to support medical research and healthcare operations. The company has established several long-term Indefinite Delivery Vehicles with the VA's Veterans Integrated Service Network 1 for streamlined procurement of its diagnostic and imaging products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $39.1k | 6/30/25 | |
| Not listed | Not listed | $39.1k | 7/1/24 |